Interferon and Other Biologic Agents for the Treatment of Kaposi's Sarcoma
- 1 April 1991
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 5 (2) , 311-322
- https://doi.org/10.1016/s0889-8588(18)30443-x
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha AThe Journal of Infectious Diseases, 1990
- CLINICAL AND VIROLOGICAL EFFECTS OF HIGH-DOSE RECOMBINANT INTERFERON-α IN DISSEMINATED AIDS-RELATED KAPOSI'S SARCOMAThe Lancet, 1988
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Therapy of Acquired Immune Deficiency Syndrome with Recombinant Interleukin-2AIDS Research and Human Retroviruses, 1987
- Spontaneous Regression of Kaposi's Sarcoma in Patients with AIDSNew England Journal of Medicine, 1985
- Impaired Production of Lymphokines and Immune (Gamma) Interferon in the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1984
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983
- Preliminary Observations on the Effect of Recombinant Leukocyte a Interferon in Homosexual Men with Kaposi's SarcomaNew England Journal of Medicine, 1983
- Effect of Interferon on Murine Leukaemia Virus Infection. IV. Formation of Non-infectious Virus in Chronically Infected CellsJournal of General Virology, 1979
- Idiopathisches multiples Pigmentsarkom der HautArchives of Dermatological Research, 1872